S005 Hot Topics in Pediatric Dermatology
DESCRIPTION
Open admission to eligible categories, no tuition or ticket
This symposium aims to give up to date, in depth information regarding new and emerging trends in pediatric dermatology. The session will cover what is new in the management of inflammatory skin diseases in children such as acne, vitiligo and hidradenitis suppurativa. It will also delve into recent innovations in the care of patients with vascular anomalies and alopecia areata. Other hot topics addressed will include management of melanocytic nevi in children and adolescents, as well as the ethics of marketing skincare products directly to tweens and teens. The symposium will stress evolving therapeutics and best practices.
LEARNING OBJECTIVES
Analyze and discuss emerging trends impacting the care of children with inflammatory and genetic skin disease with respect to diagnosis and treatment
Recognize distinct types of vascular malformations and congenital melanocytic nevi and determine which require further monitoring and/or workup.
Develop and build on your treatment regimen for children and adolescents with acne vulgaris and hidradenitis suppurativa with up to date therapies
SCHEDULE
2:00 PM
Alopecia Areata
Brittany Craiglow, MD, FAAD
2:20 PM
Atopic Dermatitis
Alan D. Irvine, MD
2:40 PM
Acne Update
Dawn Eichenfield, PhD, MD, FAAD
3:00 PM
Tween Skin Care Craze! Market Targets!
Sheilagh M. Maguiness, MD, FAAD
3:20 PM
Question and Answers
Lawrence F Eichenfield, MD, FAAD, Brittany Craiglow, MD, FAAD, Dawn Eichenfield, PhD, MD, FAAD, Alan D. Irvine, MD, Sheilagh M. Maguiness, MD, FAAD
3:30 PM
Vitiligo Update
Khaled Ezzedine, MD, PhD, IFAAD
3:50 PM
Hidradenitis Suppurativa
Haley Naik, MD, FAAD
4:10 PM
Melanocytic Nevi
Elena B. Hawryluk, MD, PhD, FAAD
4:30 PM
Vascular Anomalies: Evolving Therapies
Beth Ann Drolet, MD, FAAD
4:50 PM
Question and Answers
Lawrence F Eichenfield, MD, FAAD, Beth Ann Drolet, MD, FAAD, Khaled Ezzedine, MD, PhD, IFAAD, Elena B. Hawryluk, MD, PhD, FAAD, Sheilagh M. Maguiness, MD, FAAD, Haley Naik, MD, FAAD
SPEAKERS
Brittany Craiglow, MD, FAAD
Beth Ann Drolet, MD, FAAD
Dawn Eichenfield, PhD, MD, FAAD
Lawrence F Eichenfield, MD, FAAD
Khaled Ezzedine, MD, PhD, IFAAD
Elena B. Hawryluk, MD, PhD, FAAD
Alan D. Irvine, MD
Sheilagh M. Maguiness, MD, FAAD
Haley Naik, MD, FAAD
HANDOUTS
SPEAKER DISCLOSURES
Brittany Craiglow, MD, FAAD
AbbVie – Consultant (1099 relationship)(Fees), Speaker(Honoraria); Arcutis Biotherapeutics – Consultant (1099 relationship)(Fees), Speaker(Fees); BiologicsMD, Inc. – Consultant (1099 relationship)(Fees); Concert Pharmaceuticals – Consultant(Grants/Research Funding); CorEvitas – Consultant (1099 relationship)(Fees); Dermavant Sciences, Inc. – Advisory Board(Fees); Eli Lilly and Company – Advisory Board(Fees), Consultant(Fees), Speaker(Honoraria); GlaxoSmithKline Immunology – Consultant (1099 relationship)(Fees); Incyte – Advisory Board(Fees); Incyte Corporation – Speaker(Honoraria); Leo Pharma – Advisory Board(Fees); Novartis – Advisory Board(Fees); Pfizer Inc. – Advisory Board(Fees), Consultant(Fees), Investigator(No Compensation Received), Speaker(Honoraria); Regeneron Pharmaceuticals, Inc. – Advisory Board(Fees), Consultant (1099 relationship)(Fees), Speaker(Honoraria); Roivant Sciences – Consultant(Fees); Sanofi Genzyme – Speaker(Honoraria); Sun Pharmaceutical Industries Ltd. – Advisory Board(Fees); Takeda Pharmaceuticals USA Inc – Advisory Board(Fees);
Beth Ann Drolet, MD, FAAD
Arkayli Biosciences – Founder(Stock); Novartis Pharmaceuticals Corp. – Investigator(No Compensation Received);
Dawn Eichenfield, PhD, MD, FAAD
Amryt Pharma/ Chiesi Farmaceutici – Consultant(Fees); Apogee Therapeutics – Consultant (1099 relationship)(Fees); Beiersdorf, Inc. – Speaker(Fees), Speaker(Honoraria); DermTimes – Consultant (1099 relationship)(Fees); Eli Lilly and Company – Investigator(Grants/Research Funding); Galderma Laboratories, LP – Speaker(Fees); Incyte Corporation – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Janssen Pharmaceuticals, Inc – Investigator(Grants/Research Funding); Med-IQ – Consultant (1099 relationship)(Honoraria); NobelPharma – Advisory Board(Fees), Advisory Board(Honoraria); Ortho Dermatologics – Advisory Board(Honoraria); Pelthos Therapeutics – Advisory Board(Fees); Sanofi/Regeneron – Speaker(Fees), Speaker(Honoraria); Solici – Consultant (1099 relationship)(Fees); Sun Pharmaceutical Industries Ltd. – Consultant (1099 relationship)(Fees), Consultant (1099 relationship)(Honoraria); Verrica Pharmaceuticals Inc – Advisory Board(Fees), Speaker(Fees);
Lawrence F Eichenfield, MD, FAAD
AbbVie – Consultant(Honoraria); Abbvie – Investigator(Grants/Research Funding); Almirall – Consultant(Honoraria); Amgen – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Amryt Pharma – Consultant(Honoraria); Apogee Therapeutics – Consultant (1099 relationship)(Honoraria); Arcutis Biotherapeutics – Investigator(Grants/Research Funding); Arcutis, Inc. – Consultant (1099 relationship)(Honoraria); ASLAN Pharmaceuticals – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria); Attovia Therapeutics – Consultant (1099 relationship)(Fees); Bristol-Myers Squibb – Consultant(Honoraria); Castle Biosciences, Inc – Investigator(Grants/Research Funding); Dermata Therapeutics – Consultant (1099 relationship)(Stock); Dermavant Sciences, Inc. – Consultant(Honoraria); Eli Lilly – Consultant(Honoraria), Investigator(Grants/Research Funding); Elsevier Inc. – Other(Patent royalties or other compensation for Intellectual Property Rights); Forte Biosciences – Board of Directors(Fees), Board of Directors(Stock Options); Galderma Laboratories, L.P. – Consultant(Honoraria), Investigator(Fees); Incyte Corporation – Consultant(Honoraria); Janssen Pharmaceuticals, Inc – Consultant (1099 relationship)(Honoraria); Kenvue – Consultant (1099 relationship)(Honoraria); Krystal Biotech, Inc – Consultant(Honoraria); LEO Pharma, US – Consultant(Honoraria), Investigator(Fees); Lilly ICOS LLC – Consultant(Honoraria); Novartis – Consultant (1099 relationship)(Honoraria); Ortho Dermatologics – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Pfizer Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); Sanofi/Regeneron – Consultant(Honoraria), Investigator(Fees); Target RWE – Investigator(Grants/Research Funding); TopMD – Consultant(Stock Options); TRex Bio – Consultant (1099 relationship)(Honoraria); TrialSpark, Inc. – Consultant(Honoraria); UCB – Consultant(Honoraria); Verrica Pharmaceuticals Inc – Board of Directors(Fees), Board of Directors(Stock Options); Wiley-Blackwell – Other(Honoraria);
Khaled Ezzedine, MD, PhD, IFAAD
AbbVie – Advisory Board(Fees); BMS – Speaker(Honoraria); Eli Lilly – Speaker(Honoraria); Pfizer Inc. – Advisory Board(Fees); Pierre Fabre Dermatologie – Speaker(Honoraria);
Elena B. Hawryluk, MD, PhD, FAAD
Apogee Therapeutics – Advisory Board(Honoraria); DermTech Inc. – Investigator(No Compensation Received); Gritstone Oncology – Employee(Salary); PathAI – Advisory Board(Stock Options); Predictive Oncology, Inc – Board of Directors(Other Financial Benefit); UpToDate, Inc – Other(Other Financial Benefit);
Alan D. Irvine, MD
AbbVie – Consultant(Honoraria); Almirall – Advisory Board(Fees); Eli Lilly and Company – Consultant(Fees); Janssen Pharmaceuticals, Inc – Advisory Board(Honoraria); Leo Foundation – Independent Contractor(Fees); Leo Pharma – Speaker(Fees); Regeneron – Advisory Board(Honoraria); Regeneron Pharmaceuticals, Inc. – Investigator(Honoraria); Sanofi Genzyme – Advisory Board(Honoraria);
Sheilagh M. Maguiness, MD, FAAD
Regeneron Pharmaceuticals, Inc. – Advisory Board(Honoraria); Stryke Club LLC – Founder(No Compensation Received);
Haley Naik, MD, FAAD
23andMe – Consultant(Honoraria); AbbVie – Consultant(Honoraria), Other(Grants/Research Funding); Aristea Therapeutics, Inc. – Consultant(Honoraria); Boehringer Ingelheim – Advisory Board(Honoraria); Dava Oncology – Consultant(Honoraria); Johnson and Johnson – Consultant(Honoraria); Medscape – Consultant (1099 relationship)(Fees); Nimbus Therapeutics – Consultant(Honoraria); Novartis – Consultant (1099 relationship)(Fees); Radera Biotherapeutics, Inc. – Stockholder Private Company(Stock Options); Radera, Inc. – Stockholder Private Company(Stock Options); Sonoma Biotherapeutics – Consultant (1099 relationship)(Fees); UCB – Consultant (1099 relationship)(Fees);